What Vitamins Are Bad for Prostate Cancer?

Vitamin E supplements are the best-documented offender: a major randomized trial involving more than 35,000 men found that taking 400 IU of vitamin E daily raised prostate cancer risk by 17 percent compared with a placebo. Folic acid supplements and high circulating levels of vitamin B12 also carry concerning signals, and excessive multivitamin use has been linked to more advanced and fatal prostate cancers. The picture is more complicated than a simple good-or-bad list, though, because the form of a vitamin, the dose, and even your baseline nutritional status can flip a supposedly protective nutrient into a risk factor.

Vitamin E and the SELECT Trial

The strongest evidence against any single vitamin supplement comes from the Selenium and Vitamin E Cancer Prevention Trial, known as SELECT. It enrolled more than 35,000 men across hundreds of sites in the United States, Canada, and Puerto Rico. The trial was designed to test whether selenium, vitamin E, or both could prevent prostate cancer, based on earlier, smaller studies that had hinted at a benefit. Instead, the initial results showed a worrying, non-significant uptick in prostate cancer among men taking vitamin E alone, and the trial was stopped early in 2008.

When researchers continued to follow the men after the supplements were discontinued, the signal got worse. By 2011, men who had been randomized to vitamin E alone had a statistically significant 17 percent increase in prostate cancer risk compared with the placebo group. In concrete terms, that translated to about 1.6 additional prostate cancer cases per 1,000 men per year of supplementation.¹ Combining selenium with vitamin E did not produce the same increase, and selenium alone showed no clear effect either way.²

The dose matters here. SELECT used 400 IU of synthetic all-rac-α-tocopherol per day, far more than what you would get from food. The recommended dietary allowance for vitamin E is only about 22 IU from natural sources. Laboratory work has since revealed a possible mechanism: at high concentrations, vitamin E can paradoxically act as a pro-oxidant in prostate tissue. It ramps up certain enzymes that generate reactive oxygen species, the very molecules antioxidants are supposed to neutralize. It also boosts the production of COX-2, a pro-inflammatory enzyme linked to cancer promotion.³ In other words, vitamin E at supplement-level doses appears to flip from protective to harmful in prostate cells, a phenomenon researchers have called a “two-edged sword.”

Folic Acid Supplements

Folic acid, the synthetic form of folate added to fortified foods and sold in supplement pills, has drawn serious concern. A randomized clinical trial originally designed to study colorectal polyps tracked 643 men as a secondary analysis. Over a ten-year follow-up, men who had been taking 1 mg of folic acid daily were roughly two and a half times more likely to be diagnosed with prostate cancer than men on a placebo. The estimated ten-year probability of prostate cancer was about 10 percent in the folic acid group versus about 3 percent in the placebo group.⁴

A large collaborative analysis pooling data from six cohort studies and including thousands of prostate cancer cases confirmed the direction of that signal: men with the highest circulating folate levels had a modest increase in overall prostate cancer risk, and the association was much stronger for high-grade, aggressive tumors, with a more than two-fold increase for men in the top fifth of blood folate compared with the bottom fifth.⁵ The reason this is tricky: folate itself is essential. Your body needs it for DNA synthesis and repair. But when folate is abundant, it may help cells that are already on the path to becoming cancerous to proliferate more efficiently. Animal research has shown that folate deficiency can actually slow prostate tumor progression, probably by starving early cancer cells of the building blocks they need to copy their DNA quickly.⁶ The takeaway is not that folate is always bad: the folate you get naturally from leafy greens and legumes has not been clearly linked to increased risk. The concern is specifically about high-dose folic acid supplements.

Vitamin B12

Vitamin B12 often travels alongside folate in the same metabolic pathways, and the epidemiological data suggests it may carry similar risks. A prospective study found that men with the highest blood levels of B12 had roughly a threefold increase in prostate cancer risk compared with men in the lowest quarter, even after adjusting for folate levels and other factors.⁷ The six-cohort collaborative analysis mentioned above also found a small but statistically significant positive association between circulating B12 and prostate cancer risk.⁵

Like folate, B12 is involved in one-carbon metabolism, the set of biochemical reactions that supplies the raw materials for DNA building and gene regulation. High levels may similarly create a more hospitable environment for rapidly dividing cancer cells. Most people get adequate B12 from animal products, and supplements are primarily recommended for vegans, older adults with absorption problems, and people taking medications like metformin that interfere with B12 uptake. If you fall into one of those groups, the benefits of supplementation likely outweigh the small observed risk, but megadosing B12 “for energy” when your levels are already normal is a different story.

Beta-Carotene, Retinol, and Vitamin A

The relationship between beta-carotene and prostate cancer is not as clean-cut as the vitamin E story, but there are reasons for caution in certain groups. The CARET trial, which originally tested a combination of beta-carotene and retinol (a form of vitamin A) for lung cancer prevention, found that men taking the study supplements alongside additional dietary supplements had about a 50 percent higher risk of aggressive prostate cancer during the active trial period.⁸ Interestingly, that increased risk disappeared after the supplements were stopped.

A study measuring blood levels of various vitamin A and E forms in Singaporean men found that higher concentrations of retinol, beta-carotene, and alpha-tocopherol were all positively associated with overall prostate cancer risk. The associations were particularly strong in men who smoked or drank alcohol regularly.⁹ However, not all research agrees. One analysis found that supplemental beta-carotene was actually associated with lower risk among men who had low dietary intake of the nutrient to begin with, while no overall population-wide effect emerged.¹⁰ The pattern that keeps showing up across multiple vitamins is the same: supplements can help if you are genuinely deficient, but piling on extra when your intake is already adequate seems to push risk in the wrong direction.

Calcium and Its Vitamin D Connection

Calcium is a mineral rather than a vitamin, but it earns a place here because of how it interacts with the vitamin D system. A prospective analysis found that calcium intakes exceeding about 1,500 mg per day were associated with higher risk of advanced and fatal prostate cancer, though not with early-stage or well-differentiated tumors. The proposed mechanism is that high calcium intake suppresses the body’s production of 1,25-dihydroxyvitamin D, the most biologically active form of vitamin D, which is thought to have anti-proliferative effects in prostate tissue.¹¹

This creates an awkward situation for men on androgen deprivation therapy, a common hormonal treatment for prostate cancer that causes bone loss. Doctors routinely prescribe calcium and vitamin D to protect these men’s bones. But a critical review noted that the typical supplementation doses of 500 to 1,000 mg of calcium and 200 to 500 IU of vitamin D are too low to prevent bone loss effectively, and that calcium supplements carry potential cardiovascular and prostate cancer risks. The authors concluded that clinical trials are urgently needed to clarify the risk-benefit balance for this specific group.¹² If you are on hormonal therapy for prostate cancer, this is worth discussing with your oncologist rather than simply following a generic bone-health recommendation.

Multivitamins and the Dose Problem

Standard daily multivitamin use does not appear to raise prostate cancer risk much, if at all. The Health Professionals Follow-Up Study, which tracked tens of thousands of men over long periods, found no association between regular or long-duration multivitamin use and overall or aggressive prostate cancer.¹³

Excessive multivitamin use is a different matter. In the large NIH-AARP Diet and Health Study, men who took multivitamins more than seven times per week had about a 30 percent higher risk of advanced prostate cancer and roughly double the risk of fatal prostate cancer compared with men who never took multivitamins. The risk was strongest in men who also had a family history of prostate cancer or who layered on additional individual supplements like selenium, beta-carotene, or zinc.¹⁴ A separate large cohort study found a marginally higher prostate cancer death rate among men who took multivitamins regularly (15 or more times per month), and the risk reached statistical significance among those who used only multivitamins without adding separate antioxidant supplements.¹⁵

The practical message: a single daily multivitamin is unlikely to cause harm. Doubling or tripling up, or combining a multivitamin with high-dose individual vitamin pills, is where the evidence starts to look worrying.

Zinc Supplements Over Long Periods

Zinc is often marketed for prostate health, which makes this finding counterintuitive: a case-control study found that men who had used zinc supplements for ten or more years, whether from a multivitamin or a standalone zinc pill, had roughly double the odds of developing prostate cancer compared with non-users.¹⁶ Short-term use showed no clear risk. The prostate gland naturally accumulates zinc at higher concentrations than other tissues, and there is speculation that chronically flooding it with extra zinc could disrupt normal cellular regulation. This is one study, so the evidence is thinner than for vitamin E or folic acid, but it is worth noting given how heavily zinc is promoted to men concerned about prostate health.

The U-Shaped Curve for Selenium and Vitamin D

Some nutrients show a pattern where both too little and too much are associated with higher prostate cancer risk, while a moderate middle range appears safest. Selenium is the clearest example. A case-control study among Nigerian men found lowest prostate cancer odds at blood selenium concentrations in the middle range, with risk increasing sharply at both the lowest and highest levels. Men in the top third of selenium had more than four times the odds of prostate cancer compared with men in the middle third.¹⁷ Research using toenail selenium measurements in dogs found a remarkably similar U-shaped curve for prostate DNA damage, offering a plausible explanation for why men with the highest baseline selenium in the SELECT trial fared worse when given additional selenium supplements.¹⁸

A further complication emerged from SELECT data: men who already had high blood levels of alpha-tocopherol (a form of vitamin E) and then received selenium supplements had about double the risk of prostate cancer compared with men who started with lower vitamin E levels.¹⁹ The interaction between these two nutrients, rather than either one alone, may explain part of why the SELECT results were so disappointing.

Vitamin D shows a similar U-shaped observational pattern, with both the lowest and highest blood levels of 25-hydroxyvitamin D linked to increased prostate cancer risk in Scandinavian and other populations.²⁰ However, a large Mendelian randomization analysis, which uses genetic variants to mimic the effects of lifelong differences in vitamin D levels, found no causal relationship between circulating vitamin D and prostate cancer risk.²¹ That suggests the observational U-shape may reflect other factors rather than vitamin D itself driving the cancer.

Vitamins That Do Not Seem to Raise Risk

Not every vitamin is suspect. Vitamin C has shown no association with prostate cancer risk in a Mendelian randomization study that examined genetically predicted circulating vitamin C levels in large populations.²² That does not mean vitamin C supplements help prevent prostate cancer either; it appears to be genuinely neutral. Similarly, a Mendelian randomization study of selenium (looking at genetically determined levels rather than supplement use) found no overall association with prostate cancer, though there was a weak, non-significant trend toward increased risk of advanced disease.²³

Vitamin D supplementation itself, as distinct from calcium co-supplementation, has not been convincingly linked to increased prostate cancer risk. A randomized trial giving high-dose vitamin D to men with localized, intermediate-risk prostate cancer found no meaningful difference in time to treatment or disease progression compared with placebo.²⁴ Vitamin D appears to be neither clearly harmful nor clearly protective when it comes to prostate cancer specifically.

Why Supplements Behave Differently From Food

A theme running through all of this evidence is that getting nutrients from food rarely causes the same problems as getting them from pills. There are several reasons for this. Supplements deliver isolated compounds at doses you would almost never reach through diet alone. The 400 IU of vitamin E used in SELECT, for example, would require eating an impractical amount of nuts and seeds daily. When you eat vitamin E-rich foods, you also consume a mix of tocopherols and tocotrienols along with hundreds of other plant compounds that may modulate the vitamin’s effects. A supplement typically contains only one form, synthetic alpha-tocopherol, which behaves differently in tissue.

The same logic applies to folic acid versus food folate. Folic acid is a synthetic molecule that must be converted to its active form in the body, and at high supplemental doses, unmetabolized folic acid can circulate in the blood. Dietary folate from vegetables enters metabolism through a different route and does not produce the same surplus. This distinction matters because mandatory folic acid fortification of grain products (designed to prevent neural tube defects in developing fetuses) means many people are already consuming meaningful amounts of synthetic folic acid before they add a supplement on top.

Supplements During Prostate Cancer Treatment

Men already diagnosed with prostate cancer often wonder whether antioxidant supplements could interfere with radiation therapy, which works in part by generating oxidative damage in cancer cells. The Physicians’ Health Study examined beta-carotene use during radiation and found no significant difference in long-term outcomes: the ten-year freedom from lethal prostate cancer was 92 percent in the beta-carotene group and 89 percent in the placebo group, a non-significant difference.²⁵ That might seem reassuring, but this was one antioxidant at moderate doses, and many radiation oncologists still advise patients to stop high-dose antioxidant supplements during treatment as a precaution. The theoretical concern has not been conclusively confirmed or ruled out for all antioxidants and all treatment regimens.

A separate concern involves PSA monitoring. Some supplements can influence PSA levels independently of what the tumor is doing. A review of randomized trials noted that very high doses of vitamin D (10,000 IU or more) appeared to reduce PSA concentrations compared with standard doses.²⁶ If you are being monitored with serial PSA tests, a supplement-induced drop could mask actual disease progression. Any supplement you take should be disclosed to the team tracking your PSA.

The Regulatory Landscape for Prostate Supplements

The supplement industry operates under a regulatory framework that does not require products to prove they work before reaching store shelves. A narrative review of dietary supplement regulation highlighted that large population studies have reported significant adverse events linked to vitamin E at 400 IU, including increased prostate cancer risk, yet these products remain freely available and are sometimes marketed with implied prostate benefits.²⁷ Prostate-health supplement blends frequently contain zinc, selenium, vitamin E, and beta-carotene in combination, which is essentially the cocktail most flagged by the research discussed above. Label claims like “supports prostate health” do not require evidence of efficacy and can persist even when the balance of clinical trial data points in the opposite direction.

If you are evaluating a prostate supplement, check the label against the findings here: high-dose vitamin E, folic acid, excessive zinc, and selenium (especially if your selenium status is already adequate) are the ingredients with the most concerning evidence. A product that bundles several of these together is not necessarily helping your prostate, regardless of what the packaging says.